To Determine if Sleep Deprivation Results in Increased Esophageal Acid Exposure
NCT ID: NCT01093339
Last Updated: 2010-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2006-08-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiologic Effects of Sleep Restriction
NCT01433315
Effect of Total Sleep Deprivation on Vascular Function
NCT04535219
Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
NCT00272233
Validating the Use of a Subjectively Reported Sleep Vital Sign
NCT03018912
Study of Disrupted Sleep in Somali Americans
NCT05411029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No treatment
Subjects w/ condition and subjects w/o condition of GERD (gastroesophageal reflux disease)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 or more episodes of heartburn a week for last 3 months
Exclusion Criteria
* Underlying co-morbidity
* Narcotic medications
* Psychotropic's and Benzodiazapines medications
* Hx of psychological abnormalities
* Hx of ETOH in previous 6 mos.
* Diabetes Mellitus
* Neuropathy
* Seizures
* Sleep Apnea
* Co-morbidity that interfere w/sleep
* Women who are pregnant, or childbearing yrs, not on BC
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern Arizona VA Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SArizona VAHCS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronnie Fass, MD
Role: PRINCIPAL_INVESTIGATOR
SArizona VAHCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SArizonaVAHCS
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SLEEP DEPRIVATION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.